SIONNA THERAPEUTICS, INC. Investing Cash Flow
SIONNA THERAPEUTICS, INC. (SION) reported Investing Cash Flow of $46.29 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-06
- SIONNA THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $21.47M.
- SIONNA THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $24.82M.
- SIONNA THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $22.59M, a 48.33% increase year-over-year.
- SIONNA THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $23.10M, a 121.99% increase year-over-year.
- SIONNA THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2025 was -$118.75M.
- SIONNA THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2024 was -$126.91M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $21.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $46.29M 10-Q · filed 2026-08-06 | $68.88M derived: sum of 3 quarters · filed 2026-08-06 | $91.98M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $24.82M 10-Q · filed 2026-05-12 | $47.41M derived: sum of 2 quarters · filed 2026-05-12 | $70.51M derived: sum of 3 quarters · filed 2026-05-12 | $47.27M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $22.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $45.69M derived: sum of 2 quarters · filed 2026-03-02 | $22.45M derived: sum of 3 quarters · filed 2026-08-06 | -$118.75M 10-K · filed 2026-03-02 |
| 2025-09-30 | $23.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$143.00K derived: sum of 2 quarters · filed 2026-08-06 | -$141.34M 10-Q · filed 2025-11-05 | -$126.11M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$23.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$164.44M 10-Q · filed 2026-08-06 | -$149.21M derived: sum of 3 quarters · filed 2026-08-06 | -$138.80M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$141.19M 10-Q · filed 2026-05-12 | -$125.97M derived: sum of 2 quarters · filed 2026-05-12 | -$115.56M derived: sum of 3 quarters · filed 2026-05-12 | -$144.18M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $15.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $25.64M derived: sum of 2 quarters · filed 2026-03-02 | -$2.99M derived: sum of 3 quarters · filed 2026-03-02 | -$126.91M 10-K · filed 2026-03-02 |
| 2024-09-30 | $10.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$18.21M derived: sum of 2 quarters · filed 2025-11-05 | -$142.14M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | -$28.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$152.55M 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | -$123.93M 10-Q · filed 2025-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |